BRKR
HealthcareBruker Corporation
$51.25
+$3.14 (+6.53%)
Jan 5, 2026
Price History (1Y)
Analysis
Bruker Corporation is a healthcare company in the medical devices industry with a market capitalization of $7.79B and 11,396 employees. It generates revenue of $3.44B (TTM) and has a significant scale. The company's financial health is mixed, with a gross margin of 48.8% and operating margin of 13.0%. However, it reported a net loss of -$23.7 million (TTM) and a profit margin of -0.6%. Its balance sheet shows $2.05B in debt and $295M in cash, resulting in a debt-to-equity ratio of 82.23. Bruker's valuation is influenced by its forward P/E ratio of 23.85 and EV/EBITDA multiple of 15.60. The company has a dividend yield of 42.0% and payout ratio of 38.5%. Revenue growth has been relatively flat, with a -0.5% year-over-year decline.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $7.79B
- P/E Ratio
- N/A
- 52-Week High
- $64.64
- 52-Week Low
- $28.53
- Avg Volume
- 2.52M
- Beta
- 1.17
- Dividend Yield
- 42.00%
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United States
- Employees
- 11,396